Saichuang Far Into the Company

Saichuang Far Into the Company

You are here: HomeProductsBaclofen 1134-47-0

Contact us

  • Company Name: Saichuang Far Into the Company
  • Country/region: China
  • Contact Person: Mr.chen hang
  • Tel: 86-027-50756254
  • Email:

Baclofen 1134-47-0

  • CAS No:1134-47-0 4-amino-3-(4-chlorophenyl)butanoic acid
    Molecular Structure

    Detailed Description



    Product Name: Baclofen
    Tag: gamma-aminobutyric acid, GABA,
    Kemstro,Lioresal,Liofen,Gablofen,Lyflex,Beklo,Baclosan

    1. Basic Information:
    Product Name Baclofen
    Synonym Kemstro,Lioresal,Liofen,Gablofen,Lyflex,Beklo,Baclosan
    CAS 1134-47-0
    MF C10H12ClNO2
    MW 213.66
    EINECS 214-486-9
    Assay 99%
    Quality Standards Enterprise Standard/Pharma Grade
    Appearance White powder
    Package 25kg/Drum

    Place of Origin China
    Brand Name SMQ
    Certification ISO9001, ISO14000, KOSHER
    Model Number 1134-47-0
    MOQ 1kg
    Packaging Details 25kg/Drum, 1kg/bag
    Delivery Time 1-2 days
    Payment Terms T/T, Western union, Money gram
    Supply Ability 500000 T/Month
    2. Quick View:
    (1) Baclofen (brand names Kemstro, Lioresal, Liofen, Gablofen, Lyflex, Beklo and Baclosan) is a derivative of gamma-aminobutyric acid (GABA). It is primarily used to treat spasticity and is in the early research stages for use for the treatment of alcoholism. It is also used by compounding pharmacies in topical pain creams as a muscle relaxant.
    (2) It is an agonist for the GABAB receptors. Its beneficial effects in spasticity result from actions at spinal and supraspinal sites. Baclofen can also be used to treat hiccups.
    (3)A beneficial property of baclofen is that tolerance does not seem to occur to a significant degree — baclofen retains its therapeutic anti-spasmodic effects even after many years of continued use. Newer studies, however, indicate that tolerance may develop in some patients receiving intrathecal baclofen treatment.
    3. Medical uses:
    Baclofen is primarily used for the treatment of spastic movement disorders, especially in instances of spinal cord injury, cerebral palsy, and multiple sclerosis. Its use in people with stroke or Parkinson's disease is not recommende.
    4. Mechanism of action:
    Baclofen produces its effects by activating the GABAB receptor, similar to the drug GHB which also activates this receptor and shares some of its effects. However, baclofen does not have significant affinity for the GHB receptor, and has no known abuse potential. The modulation of the GABAB receptor is what produces baclofen's range of therapeutic properties.
  • Baclofen 1134-47-0
  • Baclofen 1134-47-0